Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat

Neuroscience Letters

Volumn 248, Issue 1, 1998, Pages 25-28

  Euchenhofer, Christian ^a   Maihöfner, Christian ^a   Brune, Kay ^a   Tegeder, Irmgard ^a   Geisslinger, Gerd ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antinociception; Cyclooxygenase 2; Diclofenac; NS 398; Rat formalin test

Indexed keywords

DICLOFENAC; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; DRUG SPECIFICITY; ENZYME INHIBITION; ENZYME SPECIFICITY; MALE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FORMALDEHYDE; ISOENZYMES; MALE; NITROBENZENES; PAIN; PAIN MEASUREMENT; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 0345310041     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00325-5     Document Type: Article

References (20)

1. Beiche F., Scheuerer S., Brune K., Geisslinger G., Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390:1996;165-169.
2. Boyce S., Chan C.C., Gordon R., Li C.S., Rodger I.W., Webb J.K., Rupniak N.M., Hill R.G. L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology. 33:1994;1609-1611.
3. Breder C.D., Dewitt D., Kraig R.P. Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355:1995;296-315.
4. DeWitt, D.L. and Smith, W.L., Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence, Proc. Natl. Acad. Sci. USA, 85 (1988) 1412-6 (published erratum appears in Proc. Natl. Acad. Sci. USA, 85(14) (1988) 5056).
5. Dirig D.M., Konin G.P., Isakson P.C., Yaksh T.L. Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release. Eur. J. Pharmacol. 331:1997;155-160.
6. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
7. Fletcher B.S., Kujubu D.A., Perrin D.M., Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:1992;4338-4344.
8. Futaki N., Yoshikawa K., Hamasaka Y., Arai I., Higuchi S., Iizuka H., Otomo S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24:1993;105-110.
9. Godbillon J., Gauron S., Metayer J.P. High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids. J. Chromatogr. 338:1985;151-159.
10. Hay C., de Belleroche J. Carrageenan-induced hyperalgesia is associated with increased cyclo-oxygenase-2 expression in spinal cord. NeuroReport. 8:1997;1249-1251.
11. Hay C.H., Trevethick M.A., Wheeldon A., Bowers J.S., de Belleroche J.S. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience. 78:1997;843-850.
12. Kujubu D.A., Fletcher B.S., Varnum B.C., Lim R.W., Herschman H.R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:1991;12866-12872.
13. Malmberg A.B., Yaksh T.L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 263:1992;136-146.
14. Mk O.B., Winn V.D., Young D.A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA. 89:1992;4888-4892.
15. Neupert W., Brugger R., Euchenhofer C., Brune K., Geisslinger G. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Br. J. Pharmacol. 122:1997;487-492.
16. Riendeau D., Percival M.D., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Falgueyret J.P., Ford-Hutchinson A.W., Gordon R., Greig G., Gresser M., Guay J., Kargman S., Leger S., Mancini J.A., O'Neil G., Ouellet M., Rodger I.W., Thérien M., Wang Z., Webb J.K., Wong E., Xu L., Young R.N., Zamboni R., Prasit P., Chan C.C. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol. 121:1997;105-117.
17. Scheuren, N., Neupert, W., Ionac, M., Neuhuber, W., Brune, K., Geisslinger, G., Peripheral noxious stimulation releases spinal PGE2 during the first phase in the formalin assay of the rat, Life Sci., 60 (1997) PL 295-300.
18. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:1994;12013-12017.
19. Simmons, D.L., Xie, W., Chipman, J.G. and Al., E., Multiple cyclooxygenases: cloning of a mitogen-inducible form. In J.M. Bailey (Ed.), Prostaglandins, Leukotriens, Lipoxins and PAF, Plenum Press, New York, 1991, pp. 67-78.
20. Yamamoto T., Nozaki-Taguchi N. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor. Brain Res. 739:1996;104-110.